Pharma & Healthcare
Global Procalcitonin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Apr 07, 25
- ID: 168204
- Pages: 106
- Figures: 107
- Views: 39
The global Procalcitonin market size was US$ 82.8 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
The global Procalcitonin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
By Type: (Dominant Segment vs High-Margin Innovation)
Procalcitonin Antigen
Procalcitonin Antibody
By Application: (Core Demand Driver vs Emerging Opportunity)
Medical Industry
Scientific Research
Veterinarian
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher in Europe)
- Emerging Product Trends: Procalcitonin Antigen adoption vs. Procalcitonin Antibody premiumization
- Demand-Side Dynamics: Medical Industry growth in China vs. Scientific Research potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Procalcitonin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Procalcitonin Antibody in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Procalcitonin Antigen dominance in Europe vs. Procalcitonin Antibody demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Procalcitonin (PCT), CAS 56645-65-9, is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Global Procalcitonin (CAS 56645-65-9) key players include Thermo Fisher, bioMerieux, BBI Solutions, Roche Diagnostics, HyTest, etc. Global top five manufacturers hold a share about 35%. Asia Pacific and Europe is the largest market, both with a share about 30%, followed by North America, with a share about 25 percent. In terms of product, Procalcitonin Antigen is the largest segment, with a share about 80%. And in terms of application, the largest application is Medical Industry, followed by Scientific Research, and Veterinarian.
The global Procalcitonin market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
BBI Solutions
ProSpec
Wondfo
Ningbo Medicalsystem Biotechnology
Wuhan Easy Diagnosis Biomedicine
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Nanjing Norman Biological Technology
Kitgen
Beijing KeyGen
Beijing Apis
By Type: (Dominant Segment vs High-Margin Innovation)
Procalcitonin Antigen
Procalcitonin Antibody
By Application: (Core Demand Driver vs Emerging Opportunity)
Medical Industry
Scientific Research
Veterinarian
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Thermo Fisher in Europe)
- Emerging Product Trends: Procalcitonin Antigen adoption vs. Procalcitonin Antibody premiumization
- Demand-Side Dynamics: Medical Industry growth in China vs. Scientific Research potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Procalcitonin market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Procalcitonin Antibody in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Scientific Research in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Procalcitonin Antigen dominance in Europe vs. Procalcitonin Antibody demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Procalcitonin Product Scope
1.2 Procalcitonin by Type
1.2.1 Global Procalcitonin Sales by Type (2020 & 2024 & 2031)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin by Application
1.3.1 Global Procalcitonin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Procalcitonin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Procalcitonin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Procalcitonin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Procalcitonin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Procalcitonin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Procalcitonin Sales Market Share by Region (2020-2025)
2.2.2 Global Procalcitonin Revenue Market Share by Region (2020-2025)
2.3 Global Procalcitonin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Procalcitonin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Procalcitonin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Procalcitonin Market Size and Prospective (2020-2031)
2.4.2 Europe Procalcitonin Market Size and Prospective (2020-2031)
2.4.3 China Procalcitonin Market Size and Prospective (2020-2031)
2.4.4 Japan Procalcitonin Market Size and Prospective (2020-2031)
2.4.5 South Korea Procalcitonin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Procalcitonin Historic Market Review by Type (2020-2025)
3.1.1 Global Procalcitonin Sales by Type (2020-2025)
3.1.2 Global Procalcitonin Revenue by Type (2020-2025)
3.1.3 Global Procalcitonin Price by Type (2020-2025)
3.2 Global Procalcitonin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Procalcitonin Sales Forecast by Type (2026-2031)
3.2.2 Global Procalcitonin Revenue Forecast by Type (2026-2031)
3.2.3 Global Procalcitonin Price Forecast by Type (2026-2031)
3.3 Different Types Procalcitonin Representative Players
4 Global Market Size by Application
4.1 Global Procalcitonin Historic Market Review by Application (2020-2025)
4.1.1 Global Procalcitonin Sales by Application (2020-2025)
4.1.2 Global Procalcitonin Revenue by Application (2020-2025)
4.1.3 Global Procalcitonin Price by Application (2020-2025)
4.2 Global Procalcitonin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Procalcitonin Sales Forecast by Application (2026-2031)
4.2.2 Global Procalcitonin Revenue Forecast by Application (2026-2031)
4.2.3 Global Procalcitonin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Procalcitonin Application
5 Competition Landscape by Players
5.1 Global Procalcitonin Sales by Players (2020-2025)
5.2 Global Top Procalcitonin Players by Revenue (2020-2025)
5.3 Global Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin as of 2024)
5.4 Global Procalcitonin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Procalcitonin, Product Type & Application
5.7 Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Procalcitonin Sales by Company
6.1.1.1 North America Procalcitonin Sales by Company (2020-2025)
6.1.1.2 North America Procalcitonin Revenue by Company (2020-2025)
6.1.2 North America Procalcitonin Sales Breakdown by Type (2020-2025)
6.1.3 North America Procalcitonin Sales Breakdown by Application (2020-2025)
6.1.4 North America Procalcitonin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Procalcitonin Sales by Company
6.2.1.1 Europe Procalcitonin Sales by Company (2020-2025)
6.2.1.2 Europe Procalcitonin Revenue by Company (2020-2025)
6.2.2 Europe Procalcitonin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Procalcitonin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Procalcitonin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Procalcitonin Sales by Company
6.3.1.1 China Procalcitonin Sales by Company (2020-2025)
6.3.1.2 China Procalcitonin Revenue by Company (2020-2025)
6.3.2 China Procalcitonin Sales Breakdown by Type (2020-2025)
6.3.3 China Procalcitonin Sales Breakdown by Application (2020-2025)
6.3.4 China Procalcitonin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Procalcitonin Sales by Company
6.4.1.1 Japan Procalcitonin Sales by Company (2020-2025)
6.4.1.2 Japan Procalcitonin Revenue by Company (2020-2025)
6.4.2 Japan Procalcitonin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Procalcitonin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Procalcitonin Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments, Downstream and Major Customers
6.5.1 South Korea Procalcitonin Sales by Company
6.5.1.1 South Korea Procalcitonin Sales by Company (2020-2025)
6.5.1.2 South Korea Procalcitonin Revenue by Company (2020-2025)
6.5.2 South Korea Procalcitonin Sales Breakdown by Type (2020-2025)
6.5.3 South Korea Procalcitonin Sales Breakdown by Application (2020-2025)
6.5.4 South Korea Procalcitonin Major Customer
6.5.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Procalcitonin Products Offered
7.1.5 Thermo Fisher Recent Development
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Information
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Roche Diagnostics Procalcitonin Products Offered
7.2.5 Roche Diagnostics Recent Development
7.3 bioMerieux
7.3.1 bioMerieux Company Information
7.3.2 bioMerieux Business Overview
7.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 bioMerieux Procalcitonin Products Offered
7.3.5 bioMerieux Recent Development
7.4 HyTest
7.4.1 HyTest Company Information
7.4.2 HyTest Business Overview
7.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 HyTest Procalcitonin Products Offered
7.4.5 HyTest Recent Development
7.5 BBI Solutions
7.5.1 BBI Solutions Company Information
7.5.2 BBI Solutions Business Overview
7.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 BBI Solutions Procalcitonin Products Offered
7.5.5 BBI Solutions Recent Development
7.6 ProSpec
7.6.1 ProSpec Company Information
7.6.2 ProSpec Business Overview
7.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 ProSpec Procalcitonin Products Offered
7.6.5 ProSpec Recent Development
7.7 Wondfo
7.7.1 Wondfo Company Information
7.7.2 Wondfo Business Overview
7.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Wondfo Procalcitonin Products Offered
7.7.5 Wondfo Recent Development
7.8 Ningbo Medicalsystem Biotechnology
7.8.1 Ningbo Medicalsystem Biotechnology Company Information
7.8.2 Ningbo Medicalsystem Biotechnology Business Overview
7.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Products Offered
7.8.5 Ningbo Medicalsystem Biotechnology Recent Development
7.9 Wuhan Easy Diagnosis Biomedicine
7.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
7.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
7.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Products Offered
7.9.5 Wuhan Easy Diagnosis Biomedicine Recent Development
7.10 Snibe
7.10.1 Snibe Company Information
7.10.2 Snibe Business Overview
7.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Snibe Procalcitonin Products Offered
7.10.5 Snibe Recent Development
7.11 Vazyme Biotech
7.11.1 Vazyme Biotech Company Information
7.11.2 Vazyme Biotech Business Overview
7.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Vazyme Biotech Procalcitonin Products Offered
7.11.5 Vazyme Biotech Recent Development
7.12 Getein Biotech
7.12.1 Getein Biotech Company Information
7.12.2 Getein Biotech Business Overview
7.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Getein Biotech Procalcitonin Products Offered
7.12.5 Getein Biotech Recent Development
7.13 Hotgen Biotech
7.13.1 Hotgen Biotech Company Information
7.13.2 Hotgen Biotech Business Overview
7.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Hotgen Biotech Procalcitonin Products Offered
7.13.5 Hotgen Biotech Recent Development
7.14 Lumigenex
7.14.1 Lumigenex Company Information
7.14.2 Lumigenex Business Overview
7.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Lumigenex Procalcitonin Products Offered
7.14.5 Lumigenex Recent Development
7.15 Nanjing Norman Biological Technology
7.15.1 Nanjing Norman Biological Technology Company Information
7.15.2 Nanjing Norman Biological Technology Business Overview
7.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Nanjing Norman Biological Technology Procalcitonin Products Offered
7.15.5 Nanjing Norman Biological Technology Recent Development
7.16 Kitgen
7.16.1 Kitgen Company Information
7.16.2 Kitgen Business Overview
7.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Kitgen Procalcitonin Products Offered
7.16.5 Kitgen Recent Development
7.17 Beijing KeyGen
7.17.1 Beijing KeyGen Company Information
7.17.2 Beijing KeyGen Business Overview
7.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Beijing KeyGen Procalcitonin Products Offered
7.17.5 Beijing KeyGen Recent Development
7.18 Beijing Apis
7.18.1 Beijing Apis Company Information
7.18.2 Beijing Apis Business Overview
7.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Beijing Apis Procalcitonin Products Offered
7.18.5 Beijing Apis Recent Development
8 Procalcitonin Manufacturing Cost Analysis
8.1 Procalcitonin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Procalcitonin
8.4 Procalcitonin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Procalcitonin Distributors List
9.3 Procalcitonin Customers
10 Procalcitonin Market Dynamics
10.1 Procalcitonin Industry Trends
10.2 Procalcitonin Market Drivers
10.3 Procalcitonin Market Challenges
10.4 Procalcitonin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Procalcitonin Product Scope
1.2 Procalcitonin by Type
1.2.1 Global Procalcitonin Sales by Type (2020 & 2024 & 2031)
1.2.2 Procalcitonin Antigen
1.2.3 Procalcitonin Antibody
1.3 Procalcitonin by Application
1.3.1 Global Procalcitonin Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Medical Industry
1.3.3 Scientific Research
1.3.4 Veterinarian
1.4 Global Procalcitonin Market Estimates and Forecasts (2020-2031)
1.4.1 Global Procalcitonin Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Procalcitonin Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Procalcitonin Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Procalcitonin Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Procalcitonin Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Procalcitonin Sales Market Share by Region (2020-2025)
2.2.2 Global Procalcitonin Revenue Market Share by Region (2020-2025)
2.3 Global Procalcitonin Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Procalcitonin Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Procalcitonin Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Procalcitonin Market Size and Prospective (2020-2031)
2.4.2 Europe Procalcitonin Market Size and Prospective (2020-2031)
2.4.3 China Procalcitonin Market Size and Prospective (2020-2031)
2.4.4 Japan Procalcitonin Market Size and Prospective (2020-2031)
2.4.5 South Korea Procalcitonin Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Procalcitonin Historic Market Review by Type (2020-2025)
3.1.1 Global Procalcitonin Sales by Type (2020-2025)
3.1.2 Global Procalcitonin Revenue by Type (2020-2025)
3.1.3 Global Procalcitonin Price by Type (2020-2025)
3.2 Global Procalcitonin Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Procalcitonin Sales Forecast by Type (2026-2031)
3.2.2 Global Procalcitonin Revenue Forecast by Type (2026-2031)
3.2.3 Global Procalcitonin Price Forecast by Type (2026-2031)
3.3 Different Types Procalcitonin Representative Players
4 Global Market Size by Application
4.1 Global Procalcitonin Historic Market Review by Application (2020-2025)
4.1.1 Global Procalcitonin Sales by Application (2020-2025)
4.1.2 Global Procalcitonin Revenue by Application (2020-2025)
4.1.3 Global Procalcitonin Price by Application (2020-2025)
4.2 Global Procalcitonin Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Procalcitonin Sales Forecast by Application (2026-2031)
4.2.2 Global Procalcitonin Revenue Forecast by Application (2026-2031)
4.2.3 Global Procalcitonin Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Procalcitonin Application
5 Competition Landscape by Players
5.1 Global Procalcitonin Sales by Players (2020-2025)
5.2 Global Top Procalcitonin Players by Revenue (2020-2025)
5.3 Global Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin as of 2024)
5.4 Global Procalcitonin Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Procalcitonin, Product Type & Application
5.7 Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Procalcitonin Sales by Company
6.1.1.1 North America Procalcitonin Sales by Company (2020-2025)
6.1.1.2 North America Procalcitonin Revenue by Company (2020-2025)
6.1.2 North America Procalcitonin Sales Breakdown by Type (2020-2025)
6.1.3 North America Procalcitonin Sales Breakdown by Application (2020-2025)
6.1.4 North America Procalcitonin Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Procalcitonin Sales by Company
6.2.1.1 Europe Procalcitonin Sales by Company (2020-2025)
6.2.1.2 Europe Procalcitonin Revenue by Company (2020-2025)
6.2.2 Europe Procalcitonin Sales Breakdown by Type (2020-2025)
6.2.3 Europe Procalcitonin Sales Breakdown by Application (2020-2025)
6.2.4 Europe Procalcitonin Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Procalcitonin Sales by Company
6.3.1.1 China Procalcitonin Sales by Company (2020-2025)
6.3.1.2 China Procalcitonin Revenue by Company (2020-2025)
6.3.2 China Procalcitonin Sales Breakdown by Type (2020-2025)
6.3.3 China Procalcitonin Sales Breakdown by Application (2020-2025)
6.3.4 China Procalcitonin Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Procalcitonin Sales by Company
6.4.1.1 Japan Procalcitonin Sales by Company (2020-2025)
6.4.1.2 Japan Procalcitonin Revenue by Company (2020-2025)
6.4.2 Japan Procalcitonin Sales Breakdown by Type (2020-2025)
6.4.3 Japan Procalcitonin Sales Breakdown by Application (2020-2025)
6.4.4 Japan Procalcitonin Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments, Downstream and Major Customers
6.5.1 South Korea Procalcitonin Sales by Company
6.5.1.1 South Korea Procalcitonin Sales by Company (2020-2025)
6.5.1.2 South Korea Procalcitonin Revenue by Company (2020-2025)
6.5.2 South Korea Procalcitonin Sales Breakdown by Type (2020-2025)
6.5.3 South Korea Procalcitonin Sales Breakdown by Application (2020-2025)
6.5.4 South Korea Procalcitonin Major Customer
6.5.5 South Korea Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Business Overview
7.1.3 Thermo Fisher Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Thermo Fisher Procalcitonin Products Offered
7.1.5 Thermo Fisher Recent Development
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Information
7.2.2 Roche Diagnostics Business Overview
7.2.3 Roche Diagnostics Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Roche Diagnostics Procalcitonin Products Offered
7.2.5 Roche Diagnostics Recent Development
7.3 bioMerieux
7.3.1 bioMerieux Company Information
7.3.2 bioMerieux Business Overview
7.3.3 bioMerieux Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.3.4 bioMerieux Procalcitonin Products Offered
7.3.5 bioMerieux Recent Development
7.4 HyTest
7.4.1 HyTest Company Information
7.4.2 HyTest Business Overview
7.4.3 HyTest Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.4.4 HyTest Procalcitonin Products Offered
7.4.5 HyTest Recent Development
7.5 BBI Solutions
7.5.1 BBI Solutions Company Information
7.5.2 BBI Solutions Business Overview
7.5.3 BBI Solutions Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.5.4 BBI Solutions Procalcitonin Products Offered
7.5.5 BBI Solutions Recent Development
7.6 ProSpec
7.6.1 ProSpec Company Information
7.6.2 ProSpec Business Overview
7.6.3 ProSpec Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.6.4 ProSpec Procalcitonin Products Offered
7.6.5 ProSpec Recent Development
7.7 Wondfo
7.7.1 Wondfo Company Information
7.7.2 Wondfo Business Overview
7.7.3 Wondfo Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Wondfo Procalcitonin Products Offered
7.7.5 Wondfo Recent Development
7.8 Ningbo Medicalsystem Biotechnology
7.8.1 Ningbo Medicalsystem Biotechnology Company Information
7.8.2 Ningbo Medicalsystem Biotechnology Business Overview
7.8.3 Ningbo Medicalsystem Biotechnology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Ningbo Medicalsystem Biotechnology Procalcitonin Products Offered
7.8.5 Ningbo Medicalsystem Biotechnology Recent Development
7.9 Wuhan Easy Diagnosis Biomedicine
7.9.1 Wuhan Easy Diagnosis Biomedicine Company Information
7.9.2 Wuhan Easy Diagnosis Biomedicine Business Overview
7.9.3 Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Wuhan Easy Diagnosis Biomedicine Procalcitonin Products Offered
7.9.5 Wuhan Easy Diagnosis Biomedicine Recent Development
7.10 Snibe
7.10.1 Snibe Company Information
7.10.2 Snibe Business Overview
7.10.3 Snibe Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Snibe Procalcitonin Products Offered
7.10.5 Snibe Recent Development
7.11 Vazyme Biotech
7.11.1 Vazyme Biotech Company Information
7.11.2 Vazyme Biotech Business Overview
7.11.3 Vazyme Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Vazyme Biotech Procalcitonin Products Offered
7.11.5 Vazyme Biotech Recent Development
7.12 Getein Biotech
7.12.1 Getein Biotech Company Information
7.12.2 Getein Biotech Business Overview
7.12.3 Getein Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Getein Biotech Procalcitonin Products Offered
7.12.5 Getein Biotech Recent Development
7.13 Hotgen Biotech
7.13.1 Hotgen Biotech Company Information
7.13.2 Hotgen Biotech Business Overview
7.13.3 Hotgen Biotech Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Hotgen Biotech Procalcitonin Products Offered
7.13.5 Hotgen Biotech Recent Development
7.14 Lumigenex
7.14.1 Lumigenex Company Information
7.14.2 Lumigenex Business Overview
7.14.3 Lumigenex Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Lumigenex Procalcitonin Products Offered
7.14.5 Lumigenex Recent Development
7.15 Nanjing Norman Biological Technology
7.15.1 Nanjing Norman Biological Technology Company Information
7.15.2 Nanjing Norman Biological Technology Business Overview
7.15.3 Nanjing Norman Biological Technology Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Nanjing Norman Biological Technology Procalcitonin Products Offered
7.15.5 Nanjing Norman Biological Technology Recent Development
7.16 Kitgen
7.16.1 Kitgen Company Information
7.16.2 Kitgen Business Overview
7.16.3 Kitgen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Kitgen Procalcitonin Products Offered
7.16.5 Kitgen Recent Development
7.17 Beijing KeyGen
7.17.1 Beijing KeyGen Company Information
7.17.2 Beijing KeyGen Business Overview
7.17.3 Beijing KeyGen Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Beijing KeyGen Procalcitonin Products Offered
7.17.5 Beijing KeyGen Recent Development
7.18 Beijing Apis
7.18.1 Beijing Apis Company Information
7.18.2 Beijing Apis Business Overview
7.18.3 Beijing Apis Procalcitonin Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Beijing Apis Procalcitonin Products Offered
7.18.5 Beijing Apis Recent Development
8 Procalcitonin Manufacturing Cost Analysis
8.1 Procalcitonin Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Procalcitonin
8.4 Procalcitonin Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Procalcitonin Distributors List
9.3 Procalcitonin Customers
10 Procalcitonin Market Dynamics
10.1 Procalcitonin Industry Trends
10.2 Procalcitonin Market Drivers
10.3 Procalcitonin Market Challenges
10.4 Procalcitonin Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Procalcitonin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Procalcitonin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Procalcitonin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Procalcitonin Sales (mg) by Region (2020-2025)
Table 5. Global Procalcitonin Sales Market Share by Region (2020-2025)
Table 6. Global Procalcitonin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Procalcitonin Revenue Share by Region (2020-2025)
Table 8. Global Procalcitonin Sales (mg) Forecast by Region (2026-2031)
Table 9. Global Procalcitonin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Procalcitonin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Procalcitonin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Procalcitonin Sales by Type (mg) & (2020-2025)
Table 13. Global Procalcitonin Sales Share by Type (2020-2025)
Table 14. Global Procalcitonin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Procalcitonin Price by Type (USD/mg) & (2020-2025)
Table 16. Global Procalcitonin Sales by Type (mg) & (2026-2031)
Table 17. Global Procalcitonin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Procalcitonin Price by Type (USD/mg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Procalcitonin Sales by Application (mg) & (2020-2025)
Table 21. Global Procalcitonin Sales Share by Application (2020-2025)
Table 22. Global Procalcitonin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Procalcitonin Price by Application (USD/mg) & (2020-2025)
Table 24. Global Procalcitonin Sales by Application (mg) & (2026-2031)
Table 25. Global Procalcitonin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Procalcitonin Price by Application (USD/mg) & (2026-2031)
Table 27. New Sources of Growth in Procalcitonin Application
Table 28. Global Procalcitonin Sales by Company (mg) & (2020-2025)
Table 29. Global Procalcitonin Sales Share by Company (2020-2025)
Table 30. Global Procalcitonin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Procalcitonin Revenue Share by Company (2020-2025)
Table 32. Global Procalcitonin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin as of 2024)
Table 33. Global Market Procalcitonin Average Price by Company (USD/mg) & (2020-2025)
Table 34. Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Procalcitonin, Product Type & Application
Table 36. Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Procalcitonin Sales by Company (2020-2025) & (mg)
Table 39. North America Procalcitonin Sales Market Share by Company (2020-2025)
Table 40. North America Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Procalcitonin Revenue Market Share by Company (2020-2025)
Table 42. North America Procalcitonin Sales by Type (2020-2025) & (mg)
Table 43. North America Procalcitonin Sales Market Share by Type (2020-2025)
Table 44. North America Procalcitonin Sales by Application (2020-2025) & (mg)
Table 45. North America Procalcitonin Sales Market Share by Application (2020-2025)
Table 46. Europe Procalcitonin Sales by Company (2020-2025) & (mg)
Table 47. Europe Procalcitonin Sales Market Share by Company (2020-2025)
Table 48. Europe Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Procalcitonin Revenue Market Share by Company (2020-2025)
Table 50. Europe Procalcitonin Sales by Type (2020-2025) & (mg)
Table 51. Europe Procalcitonin Sales Market Share by Type (2020-2025)
Table 52. Europe Procalcitonin Sales by Application (2020-2025) & (mg)
Table 53. Europe Procalcitonin Sales Market Share by Application (2020-2025)
Table 54. China Procalcitonin Sales by Company (2020-2025) & (mg)
Table 55. China Procalcitonin Sales Market Share by Company (2020-2025)
Table 56. China Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Procalcitonin Revenue Market Share by Company (2020-2025)
Table 58. China Procalcitonin Sales by Type (2020-2025) & (mg)
Table 59. China Procalcitonin Sales Market Share by Type (2020-2025)
Table 60. China Procalcitonin Sales by Application (2020-2025) & (mg)
Table 61. China Procalcitonin Sales Market Share by Application (2020-2025)
Table 62. Japan Procalcitonin Sales by Company (2020-2025) & (mg)
Table 63. Japan Procalcitonin Sales Market Share by Company (2020-2025)
Table 64. Japan Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Procalcitonin Revenue Market Share by Company (2020-2025)
Table 66. Japan Procalcitonin Sales by Type (2020-2025) & (mg)
Table 67. Japan Procalcitonin Sales Market Share by Type (2020-2025)
Table 68. Japan Procalcitonin Sales by Application (2020-2025) & (mg)
Table 69. Japan Procalcitonin Sales Market Share by Application (2020-2025)
Table 70. South Korea Procalcitonin Sales by Company (2020-2025) & (mg)
Table 71. South Korea Procalcitonin Sales Market Share by Company (2020-2025)
Table 72. South Korea Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 73. South Korea Procalcitonin Revenue Market Share by Company (2020-2025)
Table 74. South Korea Procalcitonin Sales by Type (2020-2025) & (mg)
Table 75. South Korea Procalcitonin Sales Market Share by Type (2020-2025)
Table 76. South Korea Procalcitonin Sales by Application (2020-2025) & (mg)
Table 77. South Korea Procalcitonin Sales Market Share by Application (2020-2025)
Table 78. Thermo Fisher Company Information
Table 79. Thermo Fisher Description and Business Overview
Table 80. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 81. Thermo Fisher Procalcitonin Product
Table 82. Thermo Fisher Recent Development
Table 83. Roche Diagnostics Company Information
Table 84. Roche Diagnostics Description and Business Overview
Table 85. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 86. Roche Diagnostics Procalcitonin Product
Table 87. Roche Diagnostics Recent Development
Table 88. bioMerieux Company Information
Table 89. bioMerieux Description and Business Overview
Table 90. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 91. bioMerieux Procalcitonin Product
Table 92. bioMerieux Recent Development
Table 93. HyTest Company Information
Table 94. HyTest Description and Business Overview
Table 95. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 96. HyTest Procalcitonin Product
Table 97. HyTest Recent Development
Table 98. BBI Solutions Company Information
Table 99. BBI Solutions Description and Business Overview
Table 100. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 101. BBI Solutions Procalcitonin Product
Table 102. BBI Solutions Recent Development
Table 103. ProSpec Company Information
Table 104. ProSpec Description and Business Overview
Table 105. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 106. ProSpec Procalcitonin Product
Table 107. ProSpec Recent Development
Table 108. Wondfo Company Information
Table 109. Wondfo Description and Business Overview
Table 110. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 111. Wondfo Procalcitonin Product
Table 112. Wondfo Recent Development
Table 113. Ningbo Medicalsystem Biotechnology Company Information
Table 114. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 115. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 116. Ningbo Medicalsystem Biotechnology Procalcitonin Product
Table 117. Ningbo Medicalsystem Biotechnology Recent Development
Table 118. Wuhan Easy Diagnosis Biomedicine Company Information
Table 119. Wuhan Easy Diagnosis Biomedicine Description and Business Overview
Table 120. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 121. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product
Table 122. Wuhan Easy Diagnosis Biomedicine Recent Development
Table 123. Snibe Company Information
Table 124. Snibe Description and Business Overview
Table 125. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 126. Snibe Procalcitonin Product
Table 127. Snibe Recent Development
Table 128. Vazyme Biotech Company Information
Table 129. Vazyme Biotech Description and Business Overview
Table 130. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 131. Vazyme Biotech Procalcitonin Product
Table 132. Vazyme Biotech Recent Development
Table 133. Getein Biotech Company Information
Table 134. Getein Biotech Description and Business Overview
Table 135. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 136. Getein Biotech Procalcitonin Product
Table 137. Getein Biotech Recent Development
Table 138. Hotgen Biotech Company Information
Table 139. Hotgen Biotech Description and Business Overview
Table 140. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 141. Hotgen Biotech Procalcitonin Product
Table 142. Hotgen Biotech Recent Development
Table 143. Lumigenex Company Information
Table 144. Lumigenex Description and Business Overview
Table 145. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 146. Lumigenex Procalcitonin Product
Table 147. Lumigenex Recent Development
Table 148. Nanjing Norman Biological Technology Company Information
Table 149. Nanjing Norman Biological Technology Description and Business Overview
Table 150. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 151. Nanjing Norman Biological Technology Procalcitonin Product
Table 152. Nanjing Norman Biological Technology Recent Development
Table 153. Kitgen Company Information
Table 154. Kitgen Description and Business Overview
Table 155. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 156. Kitgen Procalcitonin Product
Table 157. Kitgen Recent Development
Table 158. Beijing KeyGen Company Information
Table 159. Beijing KeyGen Description and Business Overview
Table 160. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 161. Beijing KeyGen Procalcitonin Product
Table 162. Beijing KeyGen Recent Development
Table 163. Beijing Apis Company Information
Table 164. Beijing Apis Description and Business Overview
Table 165. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 166. Beijing Apis Procalcitonin Product
Table 167. Beijing Apis Recent Development
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Procalcitonin Distributors List
Table 171. Procalcitonin Customers List
Table 172. Procalcitonin Market Trends
Table 173. Procalcitonin Market Drivers
Table 174. Procalcitonin Market Challenges
Table 175. Procalcitonin Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Procalcitonin Product Picture
Figure 2. Global Procalcitonin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Procalcitonin Sales Market Share by Type in 2024 & 2031
Figure 4. Procalcitonin Antigen Product Picture
Figure 5. Procalcitonin Antibody Product Picture
Figure 6. Global Procalcitonin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Procalcitonin Sales Market Share by Application in 2024 & 2031
Figure 8. Medical Industry Examples
Figure 9. Scientific Research Examples
Figure 10. Veterinarian Examples
Figure 11. Global Procalcitonin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Procalcitonin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 14. Global Procalcitonin Price Trends Growth Rate (2020-2031) & (USD/mg)
Figure 15. Procalcitonin Report Years Considered
Figure 16. Global Market Procalcitonin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Procalcitonin Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 20. Europe Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 22. China Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 24. Japan Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 26. South Korea Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. South Korea Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 28. Global Procalcitonin Revenue Share by Type (2020-2025)
Figure 29. Global Procalcitonin Sales Share by Type (2026-2031)
Figure 30. Global Procalcitonin Revenue Share by Type (2026-2031)
Figure 31. Global Procalcitonin Revenue Share by Application (2020-2025)
Figure 32. Global Procalcitonin Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Procalcitonin Sales Share by Application (2026-2031)
Figure 34. Global Procalcitonin Revenue Share by Application (2026-2031)
Figure 35. Global Procalcitonin Sales Share by Company (2024)
Figure 36. Global Procalcitonin Revenue Share by Company (2024)
Figure 37. Global 5 Largest Procalcitonin Players Market Share by Revenue in Procalcitonin: 2020 & 2024
Figure 38. Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Procalcitonin
Figure 40. Manufacturing Process Analysis of Procalcitonin
Figure 41. Procalcitonin Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Table 1. Global Procalcitonin Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Procalcitonin Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Procalcitonin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Procalcitonin Sales (mg) by Region (2020-2025)
Table 5. Global Procalcitonin Sales Market Share by Region (2020-2025)
Table 6. Global Procalcitonin Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Procalcitonin Revenue Share by Region (2020-2025)
Table 8. Global Procalcitonin Sales (mg) Forecast by Region (2026-2031)
Table 9. Global Procalcitonin Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Procalcitonin Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Procalcitonin Revenue Share Forecast by Region (2026-2031)
Table 12. Global Procalcitonin Sales by Type (mg) & (2020-2025)
Table 13. Global Procalcitonin Sales Share by Type (2020-2025)
Table 14. Global Procalcitonin Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Procalcitonin Price by Type (USD/mg) & (2020-2025)
Table 16. Global Procalcitonin Sales by Type (mg) & (2026-2031)
Table 17. Global Procalcitonin Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Procalcitonin Price by Type (USD/mg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Procalcitonin Sales by Application (mg) & (2020-2025)
Table 21. Global Procalcitonin Sales Share by Application (2020-2025)
Table 22. Global Procalcitonin Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Procalcitonin Price by Application (USD/mg) & (2020-2025)
Table 24. Global Procalcitonin Sales by Application (mg) & (2026-2031)
Table 25. Global Procalcitonin Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Procalcitonin Price by Application (USD/mg) & (2026-2031)
Table 27. New Sources of Growth in Procalcitonin Application
Table 28. Global Procalcitonin Sales by Company (mg) & (2020-2025)
Table 29. Global Procalcitonin Sales Share by Company (2020-2025)
Table 30. Global Procalcitonin Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Procalcitonin Revenue Share by Company (2020-2025)
Table 32. Global Procalcitonin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Procalcitonin as of 2024)
Table 33. Global Market Procalcitonin Average Price by Company (USD/mg) & (2020-2025)
Table 34. Global Key Manufacturers of Procalcitonin, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Procalcitonin, Product Type & Application
Table 36. Global Key Manufacturers of Procalcitonin, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Procalcitonin Sales by Company (2020-2025) & (mg)
Table 39. North America Procalcitonin Sales Market Share by Company (2020-2025)
Table 40. North America Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Procalcitonin Revenue Market Share by Company (2020-2025)
Table 42. North America Procalcitonin Sales by Type (2020-2025) & (mg)
Table 43. North America Procalcitonin Sales Market Share by Type (2020-2025)
Table 44. North America Procalcitonin Sales by Application (2020-2025) & (mg)
Table 45. North America Procalcitonin Sales Market Share by Application (2020-2025)
Table 46. Europe Procalcitonin Sales by Company (2020-2025) & (mg)
Table 47. Europe Procalcitonin Sales Market Share by Company (2020-2025)
Table 48. Europe Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Procalcitonin Revenue Market Share by Company (2020-2025)
Table 50. Europe Procalcitonin Sales by Type (2020-2025) & (mg)
Table 51. Europe Procalcitonin Sales Market Share by Type (2020-2025)
Table 52. Europe Procalcitonin Sales by Application (2020-2025) & (mg)
Table 53. Europe Procalcitonin Sales Market Share by Application (2020-2025)
Table 54. China Procalcitonin Sales by Company (2020-2025) & (mg)
Table 55. China Procalcitonin Sales Market Share by Company (2020-2025)
Table 56. China Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Procalcitonin Revenue Market Share by Company (2020-2025)
Table 58. China Procalcitonin Sales by Type (2020-2025) & (mg)
Table 59. China Procalcitonin Sales Market Share by Type (2020-2025)
Table 60. China Procalcitonin Sales by Application (2020-2025) & (mg)
Table 61. China Procalcitonin Sales Market Share by Application (2020-2025)
Table 62. Japan Procalcitonin Sales by Company (2020-2025) & (mg)
Table 63. Japan Procalcitonin Sales Market Share by Company (2020-2025)
Table 64. Japan Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Procalcitonin Revenue Market Share by Company (2020-2025)
Table 66. Japan Procalcitonin Sales by Type (2020-2025) & (mg)
Table 67. Japan Procalcitonin Sales Market Share by Type (2020-2025)
Table 68. Japan Procalcitonin Sales by Application (2020-2025) & (mg)
Table 69. Japan Procalcitonin Sales Market Share by Application (2020-2025)
Table 70. South Korea Procalcitonin Sales by Company (2020-2025) & (mg)
Table 71. South Korea Procalcitonin Sales Market Share by Company (2020-2025)
Table 72. South Korea Procalcitonin Revenue by Company (2020-2025) & (US$ Million)
Table 73. South Korea Procalcitonin Revenue Market Share by Company (2020-2025)
Table 74. South Korea Procalcitonin Sales by Type (2020-2025) & (mg)
Table 75. South Korea Procalcitonin Sales Market Share by Type (2020-2025)
Table 76. South Korea Procalcitonin Sales by Application (2020-2025) & (mg)
Table 77. South Korea Procalcitonin Sales Market Share by Application (2020-2025)
Table 78. Thermo Fisher Company Information
Table 79. Thermo Fisher Description and Business Overview
Table 80. Thermo Fisher Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 81. Thermo Fisher Procalcitonin Product
Table 82. Thermo Fisher Recent Development
Table 83. Roche Diagnostics Company Information
Table 84. Roche Diagnostics Description and Business Overview
Table 85. Roche Diagnostics Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 86. Roche Diagnostics Procalcitonin Product
Table 87. Roche Diagnostics Recent Development
Table 88. bioMerieux Company Information
Table 89. bioMerieux Description and Business Overview
Table 90. bioMerieux Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 91. bioMerieux Procalcitonin Product
Table 92. bioMerieux Recent Development
Table 93. HyTest Company Information
Table 94. HyTest Description and Business Overview
Table 95. HyTest Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 96. HyTest Procalcitonin Product
Table 97. HyTest Recent Development
Table 98. BBI Solutions Company Information
Table 99. BBI Solutions Description and Business Overview
Table 100. BBI Solutions Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 101. BBI Solutions Procalcitonin Product
Table 102. BBI Solutions Recent Development
Table 103. ProSpec Company Information
Table 104. ProSpec Description and Business Overview
Table 105. ProSpec Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 106. ProSpec Procalcitonin Product
Table 107. ProSpec Recent Development
Table 108. Wondfo Company Information
Table 109. Wondfo Description and Business Overview
Table 110. Wondfo Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 111. Wondfo Procalcitonin Product
Table 112. Wondfo Recent Development
Table 113. Ningbo Medicalsystem Biotechnology Company Information
Table 114. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 115. Ningbo Medicalsystem Biotechnology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 116. Ningbo Medicalsystem Biotechnology Procalcitonin Product
Table 117. Ningbo Medicalsystem Biotechnology Recent Development
Table 118. Wuhan Easy Diagnosis Biomedicine Company Information
Table 119. Wuhan Easy Diagnosis Biomedicine Description and Business Overview
Table 120. Wuhan Easy Diagnosis Biomedicine Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 121. Wuhan Easy Diagnosis Biomedicine Procalcitonin Product
Table 122. Wuhan Easy Diagnosis Biomedicine Recent Development
Table 123. Snibe Company Information
Table 124. Snibe Description and Business Overview
Table 125. Snibe Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 126. Snibe Procalcitonin Product
Table 127. Snibe Recent Development
Table 128. Vazyme Biotech Company Information
Table 129. Vazyme Biotech Description and Business Overview
Table 130. Vazyme Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 131. Vazyme Biotech Procalcitonin Product
Table 132. Vazyme Biotech Recent Development
Table 133. Getein Biotech Company Information
Table 134. Getein Biotech Description and Business Overview
Table 135. Getein Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 136. Getein Biotech Procalcitonin Product
Table 137. Getein Biotech Recent Development
Table 138. Hotgen Biotech Company Information
Table 139. Hotgen Biotech Description and Business Overview
Table 140. Hotgen Biotech Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 141. Hotgen Biotech Procalcitonin Product
Table 142. Hotgen Biotech Recent Development
Table 143. Lumigenex Company Information
Table 144. Lumigenex Description and Business Overview
Table 145. Lumigenex Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 146. Lumigenex Procalcitonin Product
Table 147. Lumigenex Recent Development
Table 148. Nanjing Norman Biological Technology Company Information
Table 149. Nanjing Norman Biological Technology Description and Business Overview
Table 150. Nanjing Norman Biological Technology Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 151. Nanjing Norman Biological Technology Procalcitonin Product
Table 152. Nanjing Norman Biological Technology Recent Development
Table 153. Kitgen Company Information
Table 154. Kitgen Description and Business Overview
Table 155. Kitgen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 156. Kitgen Procalcitonin Product
Table 157. Kitgen Recent Development
Table 158. Beijing KeyGen Company Information
Table 159. Beijing KeyGen Description and Business Overview
Table 160. Beijing KeyGen Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 161. Beijing KeyGen Procalcitonin Product
Table 162. Beijing KeyGen Recent Development
Table 163. Beijing Apis Company Information
Table 164. Beijing Apis Description and Business Overview
Table 165. Beijing Apis Procalcitonin Sales (mg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2020-2025)
Table 166. Beijing Apis Procalcitonin Product
Table 167. Beijing Apis Recent Development
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Procalcitonin Distributors List
Table 171. Procalcitonin Customers List
Table 172. Procalcitonin Market Trends
Table 173. Procalcitonin Market Drivers
Table 174. Procalcitonin Market Challenges
Table 175. Procalcitonin Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Procalcitonin Product Picture
Figure 2. Global Procalcitonin Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Procalcitonin Sales Market Share by Type in 2024 & 2031
Figure 4. Procalcitonin Antigen Product Picture
Figure 5. Procalcitonin Antibody Product Picture
Figure 6. Global Procalcitonin Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 7. Global Procalcitonin Sales Market Share by Application in 2024 & 2031
Figure 8. Medical Industry Examples
Figure 9. Scientific Research Examples
Figure 10. Veterinarian Examples
Figure 11. Global Procalcitonin Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Procalcitonin Sales Growth Rate (2020-2031) & (US$ Million)
Figure 13. Global Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 14. Global Procalcitonin Price Trends Growth Rate (2020-2031) & (USD/mg)
Figure 15. Procalcitonin Report Years Considered
Figure 16. Global Market Procalcitonin Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 17. Global Procalcitonin Revenue Market Share by Region: 2020 VS 2024
Figure 18. North America Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. North America Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 20. Europe Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 22. China Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. China Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 24. Japan Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Japan Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 26. South Korea Procalcitonin Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. South Korea Procalcitonin Sales (mg) Growth Rate (2020-2031)
Figure 28. Global Procalcitonin Revenue Share by Type (2020-2025)
Figure 29. Global Procalcitonin Sales Share by Type (2026-2031)
Figure 30. Global Procalcitonin Revenue Share by Type (2026-2031)
Figure 31. Global Procalcitonin Revenue Share by Application (2020-2025)
Figure 32. Global Procalcitonin Revenue Growth Rate by Application in 2020 & 2024
Figure 33. Global Procalcitonin Sales Share by Application (2026-2031)
Figure 34. Global Procalcitonin Revenue Share by Application (2026-2031)
Figure 35. Global Procalcitonin Sales Share by Company (2024)
Figure 36. Global Procalcitonin Revenue Share by Company (2024)
Figure 37. Global 5 Largest Procalcitonin Players Market Share by Revenue in Procalcitonin: 2020 & 2024
Figure 38. Procalcitonin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 39. Manufacturing Cost Structure of Procalcitonin
Figure 40. Manufacturing Process Analysis of Procalcitonin
Figure 41. Procalcitonin Industrial Chain
Figure 42. Channels of Distribution (Direct Vs Distribution)
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232